SUDO-550, an oral TYK2 inhibitor being developed by Sudo Biosciences, was found to be safe, well-tolerated, and to fully reach the brain in a first-in-human clinical trial involving healthy volunteers, […] The post Experimental MS therapy safely reaches brain in first human trial appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Month: November 2025
The end of daylight saving time gives me a chance to rest
On Sunday, Nov. 2, daylight saving time ended, our clocks “falling back” an hour. This time of year is difficult for many because the sun sets earlier and the evenings […] The post The end of daylight saving time gives me a chance to rest appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Midweek Inspiration
Happy midweek to y’all! I hope you have been having a good week and that you are feeling as well as you can. I set a goal to write one post a day, but unfortunately, I have not been able to. Life is an incredible thing we have been honored with, but many things can…
Trying Your Best to Catch Some ZZ’s
Sleep…. This word can generate a mixture of feelings for many. Some people find it so easy to just lay their head down, turn off the inside chatter of their mind for a bit, and fall into a good snooze. … Continue reading → Source: blog.mymsaa.org
Ultraviolet B therapy may help stabilize MS inflammation
Ultraviolet light therapy may help reduce inflammation and disease severity in people with multiple sclerosis (MS), according to data from a small Phase 1 clinical trial. Researchers used Octave’s MS […] The post Ultraviolet B therapy may help stabilize MS inflammation appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Nous biomarcadors podrien alertar sobre la progressió ‘silenciosa’ de l’esclerosi últiple
Una troballa recent, presentada al congrés ECTRIMS 2025, obre una nova via per detectar la progressió de l’Esclerosi Múltiple (EM) abans que es faci clínicament visible. Es tracta d’un conjunt de proteïnes identificades al líquid cefaloraquidi que podrien actuar com a senyal d’alerta per reconèixer el deteriorament funcional, fins i tot quan no hi ha…
Bruton’s Tyrosine Kinase Inhibitors
Tweet Bruton’s tyrosine kinase inhibitors rescue neuronal impairment caused by B cell-mediated lymphotoxin-α release. Shin J, Götz P, Sharif N, Sola-Sevilla N, Grasmuck C, Schraad M, Pape K, Muthuraman M, Fleischer V, Zandee SE, Bittner S, Vogelaar CF, Prat A, Hanuscheck N, Zipp F.Sci Transl Med. 2025;17(822):eadx2652. Although B cell depletion slows disability accrual in…
Antibodies against Epstein-Barr virus don’t predict MS progression
People with multiple sclerosis (MS) tend to have high levels of antibodies targeting the Epstein-Barr virus (EBV), but levels of these antibodies are not associated with disease activity or clinical […] The post Antibodies against Epstein-Barr virus don’t predict MS progression appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Kristina Bear – MSAA’s November 2025 Artist of the Month
MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Kristina Bear as November’s … Continue reading → Source: blog.mymsaa.org
Quality of life lower for people with MS regardless of age, gender
People living with multiple sclerosis (MS) have consistently lower quality of life than the general population — regardless of age or gender, a new study shows. The scientists also identified […] The post Quality of life lower for people with MS regardless of age, gender appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com